GlycoMimetics, Inc. is developing novel small molecule drugs to treat orphan diseases.
The Scientist – February 2012 – Female Frontrunners: How to successfully surmount the challenges women face in becoming biotech industry leaders – featuring Rachel King, CEO & Co-Founder, GlycoMimetics
CNBC Video – January 2012 – Pfizer Q4 Results with GlycoMimetics Mention
FierceBiotech – Pfizer inks $340M rare disease pact with GlycoMimetics
Metro Business Media – Hope for Sickle Cell Patients...GlycoMimetics Paving the Way
BioCentury TV – BIO's James Greenwood, Rachel King of GlycoMimetics and others discuss ideas for transforming biotech landscape
SciBx – Two edges of sickle cell disease
BioCentury TV - GlycoMimetics CEO Rachel King describes how therapeutic discovery tax grants will affect their efforts in sickle cell disease
FierceBiotech – Top 10 Women in Biotech (featuring Rachel King)
Washington Business Journal – GlycoMimetics completes drug trial Washington Business Journal – GlycoMimetics’ sickle cell drug enters human tests
Washington Business Journal – GlycoMimetics Chief Named to Biotech Institute's Board
Windhover Start-Up Magazine – Glycobiology's Second Wave
The Washington Post – GlycoMimetics' Research Taps Troublesome Carbohydrates to Combat Diseases
Signals Magazine – Glycobiology: Biotech's New Sweet Spot